This cohort study examines national rates of neoadjuvant dual-agent chemotherapy and radiation followed by surgery in patients with locally advanced esophageal carcinoma after a randomized clinical trial demonstrated a survival advantage.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7243165 | PMC |
http://dx.doi.org/10.1001/jamaoncol.2020.1065 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!